Year: 2021
Type: article
Abstract: The severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) disease (COVID-19) pandemic has caused millions of deaths worldwide. Genome-wide association studies identified the 3p21.31 region as conferring a twofold increased risk of respiratory failure. Here, using a combined multiomics and machine learning approach, we identify the gain-of-function risk A allele of an SNP, rs17713054G>A, as a probable causative variant. We show with chromosome conformation capture and gene-expression analysis that the rs17713054-affected enhancer upregulates the interacting gene, leucine zipper transcription factor like 1 (LZTFL1). Selective spatial transcriptomic analysis of lung biopsies from patients with COVID-19 shows the presence of signals associated with epithelial–mesenchymal transition (EMT), a viral response pathway that is regulated by LZTFL1. We conclude that pulmonary epithelial cells undergoing EMT, rather than immune cells, are likely responsible for the 3p21.31-associated risk. Since the 3p21.31 effect is conferred by a gain-of-function, LZTFL1 may represent a therapeutic target. SNP rs17713054 in the 3p21.31 COVID-19 risk locus is identified as a probable causative variant for disease association. Chromatin conformation and gene expression data indicate that LZTFL1 is impacted by rs17713054 in pulmonary epithelial cells.
Source: Nature Genetics
Authors: Damien J. Downes, Amy R. Cross, Peng Hua, Nigel Roberts, Ron Schwessinger, Antony J. Cutler, Altar M. Munis, Jill Brown, Olga Mielczarek, Carlos E. de Andrea, Ignacio Melero, Deborah R. Gill, Stephen C. Hyde, Julian C. Knight, John A. Todd, Stephen N. Sansom, Fadi Issa, James O. J. Davies, Jim R. Hughes
Institutions: University of Oxford, MRC Weatherall Institute of Molecular Medicine, Medical Research Council, Centre for Human Genetics, GlaxoSmithKline (United Kingdom), Clinica Universidad de Navarra, Universidad de Navarra, National Institute for Health and Care Research, NIHR Oxford Biomedical Research Centre, Kennedy Institute of Rheumatology, National Health Service
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: hybrid
Estimated APC paid: $11,390
Funders: Juvenile Diabetes Research Foundation United Kingdom, Wellcome Trust, Kennedy Trust for Rheumatology Research, National Institute for Health and Care Research, University of Oxford, Banco Bilbao Vizcaya Argentaria, Chinese Academy of Medical Sciences, Medical Research Council, NIHR Oxford Biomedical Research Centre
Awards: Human Genetics and Disease Biology: Core Renewal for the Wellcome Trust Centre for Human Genetics, Development of highly sensitive methods for defining off target mutations to enable safe gene editing of haematopoietic cells for transplantation, G3297457556, G4081636634, A new approach for linking enhancers to specific promoters., G479238701, G5024332213, G520856161, Respiratory Gene Therapy Portfolio (RGTP), G5606405986, Oxford - Genomic Medicine and Statistics, G5918494183, Investigation of hypoxia-sensing mechanisms in immune regulation, G6466068816, G7308143727, G7756437116, G7984534481, G8415457339, A systematic approach to understanding the biology underpinning GWAS hits., Characterising extreme innate immune response phenotypes informative for disease using a functional genomics approach, G981451289
OpenAlex ID: W3210769714
